Search ALUR
Allurion Technologies Inc.
OTC Markets OTCPK · CIK 1964979
Last close0.6
Daily change-0.18 (-22.78%)
10 Years gain-99.76%
Dividends TTM0
Dividend yield0.00%
Fundamental Analysis
ALUR · STANDARD
SIC 3841 · Surgical & Medical Instruments & Apparatus · Fiscal year end 1231
Fundamental
13.2Momentum
0.0Acceleration
0.0Confidence
63.0Annual Revenue4
Quarterly Revenue12
Annual CFO4
Balance SheetAvailable
RankingEligible
Score Breakdown
Growth0.0 / 25
Quality12.5 / 25
Capital Efficiency0.0 / 20
Balance Sheet0.0 / 15
Shareholder Economics0.0 / 10
Forward Indicators0.0 / 5
Signals
Net debt reductionNet debt declined versus the comparison period.
Warnings
Gross margin compression · MEDIUMGross margin compressed by 10.5478 percentage points.
Operating margin compression · MEDIUMOperating margin compressed by 57.0225 percentage points.
Heavy share dilution · HIGHDiluted share count increased 420.224%.
Key Metrics
Revenue Growth TTM-67.43%OK
Revenue CAGR 3Y-38.1%OK
Gross Margin63.11%OK
Operating Margin-189.47%OK
FCF Marginn/aMISSING
FCF Growthn/aINSUFFICIENT_HISTORY
ROICn/aMISSING
Incremental Operating Margin 3Yn/aNOT_MEANINGFUL
Net Debt / CFOn/aNOT_MEANINGFUL
Diluted Share Growth 1Y420.22%OK
SBC / Revenuen/aMISSING
SBC / FCFn/aNOT_MEANINGFUL
Financial History
| Period | Revenue | Gross Profit | Operating Income | CFO | FCF | Gross Margin | Op Margin | FCF Margin | ROIC | Shares |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025 FY Dec 31, 2025 | $15.23M | $9.57M | -$30.16M | -$28.95M | n/a | 62.84% | -198.01% | n/a | n/a | 7.54M |
| 2025 FY Dec 31, 2024 | $32.11M | $21.50M | -$50.20M | -$42.30M | -$42.91M | 66.97% | -156.33% | -133.64% | n/a | 2.25M |
| 2023 FY Dec 31, 2023 | $53.47M | $41.50M | -$79.08M | -$63.98M | -$65.59M | 77.61% | -147.9% | -122.67% | n/a | 1.42M |
| 2023 FY Dec 31, 2022 | $64.21M | $50.73M | -$32.01M | -$46.98M | -$48.53M | 79% | -49.85% | -75.58% | n/a | 1.08M |
Formula Trace
| Metric | Value | Formula | Status | Source |
|---|---|---|---|---|
| Revenue TTM | $14.56M | sum latest 4 fiscal quarters Revenue | OK | 0001193125-26-226960, 0000950170-25-110188 |
| Revenue Growth TTM | -67.43% | Revenue_TTM / Revenue_TTM_1Y_ago - 1 | OK | 0001193125-26-226960, 0000950170-25-110188 |
| Revenue CAGR 3Y | -38.1% | (Revenue_current / Revenue_3Y_ago)^(1/3) - 1 | OK | 0001193125-26-130483 |
| Revenue CAGR 5Y | n/a | (Revenue_current / Revenue_5Y_ago)^(1/5) - 1 | INSUFFICIENT_HISTORY | 0001193125-26-130483 |
| Gross Profit CAGR 3Y | -42.64% | (GrossProfit_current / GrossProfit_3Y_ago)^(1/3) - 1 | OK | 0001193125-26-130483 |
| Operating Income Growth | n/a | OperatingIncome_current / OperatingIncome_prior_year - 1 | INSUFFICIENT_HISTORY | 0001193125-26-226960, 0000950170-25-110188 |
| FCF Growth | n/a | FCF_current / FCF_prior_year - 1 | INSUFFICIENT_HISTORY | derived |
| Revenue Growth Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| Gross Profit Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| Operating Income Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| FCF Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| Gross Margin | 63.11% | Gross Profit / Revenue | OK | 0001193125-26-226960, 0000950170-25-110188 |
| Operating Margin | -189.47% | Operating Income / Revenue | OK | 0001193125-26-226960, 0000950170-25-110188 |
| Net Debt / CFO | n/a | Net Debt / CFO | NOT_MEANINGFUL | 0001193125-26-226960 |
| Current Ratio | 0.3x | Current Assets / Current Liabilities | OK | derived |
| Revenue per Diluted Share | $1.09 | Revenue / Diluted Shares | OK | 0001193125-26-226960, 0000950170-25-110188 |
| SBC / FCF | n/a | SBC / FCF | NOT_MEANINGFUL | derived |
| Dividend Payout Ratio | n/a | Cash dividends paid / Net income | NOT_MEANINGFUL | 0001193125-26-130483 |